Molina Healthcare (NYSE:MOH) Releases FY 2025 Earnings Guidance

Molina Healthcare (NYSE:MOH) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 24.500- for the period, compared to the consensus EPS estimate of 26.070. The company issued revenue guidance of -.

Molina Healthcare Price Performance

Molina Healthcare stock traded up $2.04 during mid-day trading on Wednesday, hitting $317.45. 806,764 shares of the company traded hands, compared to its average volume of 577,415. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.55 and a current ratio of 1.54. The stock has a fifty day moving average price of $298.78 and a 200-day moving average price of $318.38. Molina Healthcare has a one year low of $272.69 and a one year high of $423.92. The stock has a market cap of $18.16 billion, a price-to-earnings ratio of 16.12, a price-to-earnings-growth ratio of 0.96 and a beta of 0.54.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 27.88% and a net margin of 2.92%. On average, equities analysts predict that Molina Healthcare will post 23.44 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have weighed in on MOH shares. JPMorgan Chase & Co. restated a “neutral” rating and set a $350.00 target price (down previously from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Wells Fargo & Company lifted their price objective on shares of Molina Healthcare from $360.00 to $362.00 and gave the company an “equal weight” rating in a research report on Monday, November 4th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $406.00 price objective on shares of Molina Healthcare in a research note on Thursday, October 24th. Truist Financial dropped their price target on Molina Healthcare from $400.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Barclays raised their target price on shares of Molina Healthcare from $359.00 to $372.00 and gave the stock an “equal weight” rating in a report on Friday, October 25th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, four have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $359.18.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.